PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsrocky mountain spotted fever
MeSH D012373 - rocky mountain spotted fever
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D000073605:Spotted fever group rickettsiosis
0 Companies
0 Drugs
Success rate
D012373: 
Rocky mountain spotted fever
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaDoxycycline hyclate Doxy-lemmon  1984-06-15   
MylanDoxycycline hyclate Doxycycline  2012-08-21   
Doxycycline hyclate Doxycycline Hyclate  1983-02-15   
Mayne GroupDoxycycline hyclate Doryx  1985-07-22   
Doxycycline hyclate Doryx Mpc 2022-12-15 2005-05-06   
Chartwell PharmaceuticalsDoxycycline hyclate Acticlate  2014-07-25   
Doxycycline hyclate Acticlate Cap  2016-04-26   
Doxycycline Doxycycline  2008-07-16   
Doxycycline hyclate Doxycycline Hyclate  1984-09-11   
Doxycycline hyclate Lymepak  2018-06-15   
Doxycycline Monodox  1989-12-29   
Lupin ResearchDoxycycline Doxycycline  2013-03-18   
Doxycycline hyclate Doxycycline Hyclate  2023-08-11   
SandozDoxycycline Doxycycline  2000-06-30   
Bausch Health CompaniesDoxycycline hyclate Doxycycline Hyclate  2005-12-21   
PfizerDoxycycline hyclate Vibra-tabs  1982-01-01   
Doxycycline, Doxycycline hyclate Vibramycin  1982-01-01   
Cosette Pharmaceuticals Doxycycline Doxycycline  2015-05-28   
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
0%
0/0
Phase 3
100%
4/4
Approved: 4Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Journey Medical
Pfizer
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use